Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report
Jaclyn B Murry, Kalotina Machini, Ozge Ceyhan-Birsoy, Amy Kritzer, Joel B Krier, Matthew S Lebo, Shawn Fayer, Casie A Genetti, Grace E VanNoy, Timothy W Yu, Pankaj B Agrawal, Richard B Parad, Ingrid A Holm, Amy L McGuire, Robert C Green, Alan H Beggs, Heidi L Rehm, BabySeq Project Team, Pankaj B Agrawal, Alan H Beggs, Wendi N Betting, Ozge Ceyhan-Birsoy, Kurt D Christensen, Dmitry Dukhovny, Shawn Fayer, Leslie A Frankel, Casie A Genetti, Chet Graham, Robert C Green, Amanda M Gutierrez, Maegan Harden, Ingrid A Holm, Joel B Krier, Matthew S Lebo, Harvey L Levy, Xingquan Lu, Kalotina Machini, Amy L McGuire, Jaclyn B Murry, Medha Naik, Tiffany Nguyen, Richard B Parad, Hayley A Peoples, Stacey Pereira, Devan Petersen, Uma Ramamurthy, Vivek Ramanathan, Heidi L Rehm, Amy Roberts, Jill O Robinson, Serguei Roumiantsev, Talia S Schwartz, Tina K Truong, Grace E VanNoy, Susan E Waisbren, Timothy W Yu, Jaclyn B Murry, Kalotina Machini, Ozge Ceyhan-Birsoy, Amy Kritzer, Joel B Krier, Matthew S Lebo, Shawn Fayer, Casie A Genetti, Grace E VanNoy, Timothy W Yu, Pankaj B Agrawal, Richard B Parad, Ingrid A Holm, Amy L McGuire, Robert C Green, Alan H Beggs, Heidi L Rehm, BabySeq Project Team, Pankaj B Agrawal, Alan H Beggs, Wendi N Betting, Ozge Ceyhan-Birsoy, Kurt D Christensen, Dmitry Dukhovny, Shawn Fayer, Leslie A Frankel, Casie A Genetti, Chet Graham, Robert C Green, Amanda M Gutierrez, Maegan Harden, Ingrid A Holm, Joel B Krier, Matthew S Lebo, Harvey L Levy, Xingquan Lu, Kalotina Machini, Amy L McGuire, Jaclyn B Murry, Medha Naik, Tiffany Nguyen, Richard B Parad, Hayley A Peoples, Stacey Pereira, Devan Petersen, Uma Ramamurthy, Vivek Ramanathan, Heidi L Rehm, Amy Roberts, Jill O Robinson, Serguei Roumiantsev, Talia S Schwartz, Tina K Truong, Grace E VanNoy, Susan E Waisbren, Timothy W Yu
Abstract
Here, we report a newborn female infant from the well-baby cohort of the BabySeq Project who was identified with compound heterozygous BTD gene variants. The two identified variants included a well-established pathogenic variant (c.1612C>T, p.Arg538Cys) that causes profound biotinidase deficiency (BTD) in homozygosity. In addition, a novel splice variant (c.44+1G>A, p.?) was identified in the invariant splice donor region of intron 1, potentially predictive of loss of function. The novel variant was predicted to impact splicing of exon 1; however, given the absence of any reported pathogenic variants in exon 1 and the presence of alternative splicing with exon 1 absent in most tissues in the GTEx database, we assigned an initial classification of uncertain significance. Follow-up medical record review of state-mandated newborn screen (NBS) results revealed an initial out-of-range biotinidase activity level. Levels from a repeat NBS sample barely passed cutoff into the normal range. To determine whether the infant was biotinidase-deficient, subsequent diagnostic enzyme activity testing was performed, confirming partial BTD, and resulted in a change of management for this patient. This led to reclassification of the novel splice variant based on these results. In conclusion, combining the genetic and NBS results together prompted clinical follow-up that confirmed partial BTD and informed this novel splice site's reclassification, emphasizing the importance of combining iterative genetic and phenotypic evaluations.
Keywords: abnormal enzyme/coenzyme activity.
© 2018 Murry et al.; Published by Cold Spring Harbor Laboratory Press.
References
- Ceyhan-Birsoy O, Machini K, Lebo MS, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire A, Green RC, Beggs AH, et al. 2017. A curated gene list for reporting results of newborn genomic sequencing. Genet Med 19: 809–818.
- Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536: 285–291.
- Pomponio RJ, Norrgard KJ, Hymes J, Reynolds TR, Buck GA, Baumgartner R, Suormala T, Wolf B. 1997. Arg538 to Cys mutation in a CpG dinucleotide of the human biotinidase gene is the second most common cause of profound biotinidase deficiency in symptomatic children. Hum Genet 99: 506–512.
- Senanayake DN, Jasinge EA, Pindolia K, Wanigasinghe J, Monaghan K, Suchy SF, Wei S, Jaysena S, Wolf B. 2015. First contiguous gene deletion causing biotinidase deficiency: the enzyme deficiency in three Sri Lankan children. Mol Genet Metab Rep 2: 81–84.
- Stanley CM, Hymes J, Wolf B. 2004. Identification of alternatively spliced human biotinidase mRNAs and putative localization of endogenous biotinidase. Mol Genet Metab 81: 300–312.
- Strovel ET, Cowan TM, Scott AI, Wolf B. 2017. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genet Med 19 10.1038/gim.2017.84.
- Wolf B. 1993. Biotinidase deficiency. 2000 Mar 24 [Updated 2016 Jun 9] In GeneReviews® [Internet] (ed. Adam MP, Ardinger HH, Pagon RA, et al.), University of Washington, Seattle, Seattle, WA: 1993–2018. Available from .
Source: PubMed